Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2025

TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer

Presenter: Carlos Eduardo Vergara Uzcategui

October 28, 2025

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 185: The Incidence of In-Stent Restenosis Among Patients with Cancer

Presenter: Akram Mahdi

October 26, 2025

Presentation TCT 2025

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

Presenter: Philipp Kiefer

October 26, 2025

Presentation TCT 2025

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

Presenter: Hasnan M. Ijaz

October 26, 2025

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

News Daily News

Roughly Half of Patients Don’t Have Symptoms Prior to a First MI

July 09, 2025

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

June 17, 2025

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

News Daily News

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

June 13, 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

News Conference News ESOC 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

June 02, 2025

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

News Conference News ESC Heart Failure 2025

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

May 21, 2025

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

May 16, 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

News Conference News European Congress on Obesity 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

April 23, 2025

Cardiotoxicity Rare With Common GI Chemotherapy

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

April 15, 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

News Conference News EHRA 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

March 31, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

March 29, 2025

What’s Going to Be Hot at ACC 2025?

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.